|
RMT also continues to set the standard in platform reliability with rmtHealthCheck™. This built-in performance monitoring tool proactively detects and reports network issues, helping IT teams and clinicians prevent disruptions before they impact patient care. “Intra-procedural remote evaluation is no longer optional—it’s expected,” said Don Marchon, Founder & CEO of RMT. “ROSE Now™ and Section Now™ give cytopathologists and surgical pathologists the tools to act faster and with confidence, even during time-critical procedures like FNAs and frozen sections.”
Summit attendees will also receive a preview of upcoming feature releases, including secure integrated chat, enhanced admin controls, and expanded system performance insights—all designed to maximize uptime, productivity, and confidence in every evaluation.
Visit Remote Medical Technologies at Booth #S12 to experience ROSE Now™ and Section Now™ in action.
For more information, contact RMT at 631-491-6614 or info@rmtcentral.com.
|